Cargando…
When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
New more powerful therapies for the treatment of multiple sclerosis may also confer a potential for unprecedented life-endangering side effects. How does a physician respond to a patient’s request for a treatment the benefit of which cannot be clearly established as worth its risk? The current chall...
Autor principal: | Kachuck, Norman J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090283/ https://www.ncbi.nlm.nih.gov/pubmed/21573081 http://dx.doi.org/10.2147/NDT.S17522 |
Ejemplares similares
-
Failures to disagree are essential for environmental science to effectively influence policy development
por: Norberg, Jon, et al.
Publicado: (2022) -
The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020) -
Neurologists’ views on patient reported outcomes in multiple sclerosis care
por: Reitzel, Signe Baattrup, et al.
Publicado: (2022) -
In Defense of Best Interests: When Parents and Clinicians Disagree
por: Coulson-Smith, Peta, et al.
Publicado: (2018) -
Patient Expression of Emotions and Neurologist Responses in First Multiple Sclerosis Consultations
por: Del Piccolo, Lidia, et al.
Publicado: (2015)